Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Jun

Showing results (191-200 of 230) with videos related to

Pageof 23
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|January 9, 2020
Synthesis, <i>in vitro</i> screening and molecular docking of isoquinolinium-5-carbaldoximes as acetylcholinesterase and butyrylcholinesterase reactivatorsDavid Malinak, Rafael Dolezal, Vendula Hepnarova, et al.
European Journal of Medicinal Chemistry|July 21, 2020
Discovery of novel berberine derivatives with balanced cholinesterase and prolyl oligopeptidase inhibition profileKaterina Sobolova, Martina Hrabinova, Vendula Hepnarova, et al.
Drug Design, Development and Therapy|March 23, 2018
Development of small bisquaternary cholinesterase inhibitors as drugs for pre-treatment of nerve agent poisoningsKamil Kuca, Jana Zdarova Karasova, Ondrej Soukup, et al.
Journal of Inorganic Biochemistry|May 28, 2016
Targeting copper(II)-induced oxidative stress and the acetylcholinesterase system in Alzheimer's disease using multifunctional tacrine-coumarin hybrid moleculesSlavka Hamulakova, Patrik Poprac, Klaudia Jomova, et al.
Toxicology Letters|June 21, 2011
Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agentsMarie Trovaslet-Leroy, Lucie Musilova, Frédérique Renault, et al.
Chemico-Biological Interactions|August 18, 2025
Nanodiamond mediated delivery of pyridinium oxime antidotes to central nervous system for potential treatment of exposure to nerve agentsDenys Bondar, Olga Smirnova, Nandish M Nagappa, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2021
Huprine Y - Tryptophan heterodimers with potential implication to Alzheimer's disease treatmentEva Mezeiova, Martina Hrabinova, Vendula Hepnarova, et al.
Chemico-Biological Interactions|March 17, 2024
Uncharged mono- and bisoximes: In search of a zwitterion to countermeasure organophosphorus intoxicationLukas Gorecki, Aneta Markova, Vendula Hepnarova, et al.
Chemico-Biological Interactions|October 6, 2023
Sustainable ionic liquids-based molecular platforms for designing acetylcholinesterase reactivatorsIllia V Kapitanov, Marcel Špulák, Milan Pour, et al.
Biomolecules|December 30, 2020
Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and <i>N</i>-Methyl-d-Aspartate Receptor AntagonistsJan Konecny, Anna Misiachna, Martina Hrabinova, et al.
Pageof 23

Showing results (191-200 of 230) with videos related to

Sort By:
Pageof 23
Journal of Enzyme Inhibition and Medicinal Chemistry|January 9, 2020
Synthesis, <i>in vitro</i> screening and molecular docking of isoquinolinium-5-carbaldoximes as acetylcholinesterase and butyrylcholinesterase reactivatorsDavid Malinak, Rafael Dolezal, Vendula Hepnarova, et al.
European Journal of Medicinal Chemistry|July 21, 2020
Discovery of novel berberine derivatives with balanced cholinesterase and prolyl oligopeptidase inhibition profileKaterina Sobolova, Martina Hrabinova, Vendula Hepnarova, et al.
Drug Design, Development and Therapy|March 23, 2018
Development of small bisquaternary cholinesterase inhibitors as drugs for pre-treatment of nerve agent poisoningsKamil Kuca, Jana Zdarova Karasova, Ondrej Soukup, et al.
Journal of Inorganic Biochemistry|May 28, 2016
Targeting copper(II)-induced oxidative stress and the acetylcholinesterase system in Alzheimer's disease using multifunctional tacrine-coumarin hybrid moleculesSlavka Hamulakova, Patrik Poprac, Klaudia Jomova, et al.
Toxicology Letters|June 21, 2011
Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agentsMarie Trovaslet-Leroy, Lucie Musilova, Frédérique Renault, et al.
Chemico-Biological Interactions|August 18, 2025
Nanodiamond mediated delivery of pyridinium oxime antidotes to central nervous system for potential treatment of exposure to nerve agentsDenys Bondar, Olga Smirnova, Nandish M Nagappa, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2021
Huprine Y - Tryptophan heterodimers with potential implication to Alzheimer's disease treatmentEva Mezeiova, Martina Hrabinova, Vendula Hepnarova, et al.
Chemico-Biological Interactions|March 17, 2024
Uncharged mono- and bisoximes: In search of a zwitterion to countermeasure organophosphorus intoxicationLukas Gorecki, Aneta Markova, Vendula Hepnarova, et al.
Chemico-Biological Interactions|October 6, 2023
Sustainable ionic liquids-based molecular platforms for designing acetylcholinesterase reactivatorsIllia V Kapitanov, Marcel Špulák, Milan Pour, et al.
Biomolecules|December 30, 2020
Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and <i>N</i>-Methyl-d-Aspartate Receptor AntagonistsJan Konecny, Anna Misiachna, Martina Hrabinova, et al.
Pageof 23